Bruker Corp (NASDAQ:BRKR)
| 62.19 Delayed Data As of Sep 22 |  +0.01 / +0.02%Today’s Change | 48.42 Today|||52-Week Range 84.84 | -9.01% Year-to-Date |
Latest BRKR News | Press Releases
| Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities Sep 19 / Zacks.com - Paid Partner Content | Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems Sep 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 62.18 |
| Today’s open | 62.63 |
| Day’s range | 61.97 - 63.04 |
| Volume | 43,292 |
| Average volume (3 months) | 881,554 |
| Market cap | $9.1B |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +9.06% |
| Earnings growth (this year) | +10.49% |
| Earnings growth (next 5 years) | +18.47% |
| Revenue growth (last year) | +4.67% |
| P/E ratio | 28.8 |
| Price/Sales | 4.04 |
| Price/Book | 8.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QGENQiagen NV | -0.19 | -0.48% |
| BIOBio Rad Laboratories... | -4.03 | -1.13% |
| RVTYRevvity Inc | +1.01 | +0.93% |
| ---- |
Data as of 4:00pm ET, 09/22/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $296.6M |
| Net profit margin | 11.72% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Billerica, Massachusetts |
Forecasts
